Skip to main content
Fig. 3 | Virology Journal

Fig. 3

From: Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview

Fig. 3

Schematic illustration of the characteristics of the nanovaccines against the SARS-CoV-2 infection. Nanovaccines can enhance cell-intermediated and antibody-intermediated immunity, also immunologic memories over time. Nanovaccines are designed via physical adsorption, chemical conjugation, encapsulation, or physical mixing of antigens with NPs. In addition, antigen delivery by NPs to infiltrated tissue or organ targeting is related to the size of the NPs.

Back to article page

Virology Journal

ISSN: 1743-422X